School of Medicine

A new study by WashU Medicine researchers in mice sheds light on the brain’s response to a high-fat and very low-carb diet, which has long been known to help treat some people with epilepsy.

Researchers at WashU Medicine have found a strong correlation between obesity in one or both parents during pregnancy and their child’s risk of developing a common liver disorder.

Machine learning researchers at Washington University in St. Louis used artificial intelligence to help with early detection of spinal cord disease.

Denise M.S. Willers, MD, a clinician renowned for patient-centered care and academic excellence, has been named the new director of the WashU Medicine Division of Academic Specialists in Obstetrics & Gynecology.

WashU Medicine researchers have developed a method to predict when someone is likely to develop symptoms of Alzheimer’s disease using a single blood test.

WashU Medicine researchers have received a grant from the National Institutes of Health (NIH) to continue a study of families with a history of extreme longevity, seeking genetic clues to healthy aging.

Michael J. Greenberg, at WashU Medicine, has received two grants from the National Institutes of Health (NIH) to investigate the complex roles of troponin — a critical protein in the heart — in various forms of heart failure.

Philip Payne, vice chancellor for biomedical informatics and data science at WashU Medicine and chief health AI officer for BJC Health and WashU Medicine, will lead the American Medical Informatics Association.

Research from WashU psychologists finds perception of neighborhood safety affects brain development.

As WashU’s vice chancellor for innovation and commercialization, Doug Frantz helps speed scientific discoveries into real-world therapies and devices. He works to develop strategic partnerships with industry and enhance WashU’s commercialization efforts.